US 7521211
IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof
granted A61KA61K38/00
Quick answer
US patent 7521211 (IGF-1 and IGF-2 chimeric polypeptides and therapeutic uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/00